Piet Herdewijn
- Virology top 0.1%
- HIV Research and Treatment 60
- Infectious Diseases top 0.1%
- HIV/AIDS drug development and treatment 202
- Organic Chemistry top 0.2%
- Carbohydrate Chemistry and Synthesis 123
- Synthesis and Characterization of Heterocyclic Compounds 83
- Molecular Biology top 0.2%
- DNA and Nucleic Acid Chemistry 319
- Advanced biosensing and bioanalysis techniques 154
- RNA and protein synthesis mechanisms 138
- Biochemical and Molecular Research 123
- Physiology top 0.2%
- Co-authors
- Erik De ClercqArthur Van AerschotJan BalzariniRudi PauwelsMasanori BabaJef RozenskiJan DesmyterRobert Snoeck
- Partner nations
- BelgiumUnited StatesFrance
In The Last Decade
Piet Herdewijn
765 papers receiving 19.0k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Virology 2.9k
- Infectious Diseases 6.0k
- Organic Chemistry 5.2k
- Molecular Biology 12.5k
- Physiology 583
Countries citing papers authored by Piet Herdewijn
This map shows the geographic impact of Piet Herdewijn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piet Herdewijn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piet Herdewijn more than expected).
Fields of papers citing papers by Piet Herdewijn
This network shows the impact of papers produced by Piet Herdewijn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piet Herdewijn. The network helps show where Piet Herdewijn may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Piet Herdewijn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 23 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 6 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 5 | |
| 6 | 2022 | 6 | |
| 7 | 2021 | 7 | |
| 8 | 2020 | 30 | |
| 9 | 2020 | 1 | |
| 10 | 2019 | 10 | |
| 11 | 2016 | 13 | |
| 12 | Synthetic Genetic Polymers Capable of Heredity and Evolutionbreakdown → | 2012 | 546 |
| 13 | 2004 | 1 | |
| 14 | 2002 | 5 | |
| 15 | Conformational and stereochemical analysis as starting point for the design of antiviral compounds | 1999 | 1 |
| 16 | Antisense oligonucleotides as anticancer agents | 1998 | 1 |
| 17 | 1995 | 2 | |
| 18 | 2',3'-Dideoxynucleoside analogues as anti-HIV agents | 1993 | 6 |
| 19 | Antibiotics and antiviral agents | 1991 | 1 |
| 20 | Regeneration of the antiviral drug (E)-5-(2-bromovinyl)-2'-deoxyuridine in vivo. | 1984 | 3 |
About Piet Herdewijn
Piet Herdewijn is a scholar working on Virology, Infectious Diseases and Organic Chemistry, having authored 787 papers that have together received 19.5k indexed citations. Recurring topics across this work include DNA and Nucleic Acid Chemistry (319 papers), HIV/AIDS drug development and treatment (202 papers), Advanced biosensing and bioanalysis techniques (154 papers), RNA and protein synthesis mechanisms (138 papers), Carbohydrate Chemistry and Synthesis (123 papers), Biochemical and Molecular Research (123 papers), Synthesis and Characterization of Heterocyclic Compounds (83 papers) and HIV Research and Treatment (60 papers). The work is most often cited by research in Virology (2.9k citations), Infectious Diseases (6.0k citations) and Organic Chemistry (5.2k citations). Piet Herdewijn has collaborated with scholars based in Belgium, United States and France. Frequent co-authors include Erik De Clercq, Arthur Van Aerschot, Jan Balzarini, Rudi Pauwels, Masanori Baba, Jef Rozenski, Jan Desmyter, Robert Snoeck, Roger Busson and Dominique Schols. Their work appears in journals such as Nature, Science and Chemical Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.